You are here

Clinical Trials: Vascular Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Thursday, January 26, 2023 - 12:00
Condition:   Ischemic Stroke
Intervention:   Biological: MSC
Sponsor:   Shanghai IxCell Biotechnology Co., LTD
Not yet recruiting
Posted: Thursday, January 26, 2023 - 12:00
Conditions:   Multiple System Atrophy;   MSA - Multiple System Atrophy
Interventions:   Drug: hOMSC300;   Other: Sham Procedure
Sponsor:   Cytora Ltd.
Posted: Friday, December 30, 2022 - 12:00
Conditions:   Myocardial Infarction;   Myocardial Ischemia;   Myocardial Stunning
Intervention:   Biological: mitochondria and MSC-derived exosomes
Sponsor:   Tehran University of Medical Sciences
Posted: Wednesday, November 30, 2022 - 12:00
Conditions:   Ischemic Heart Disease;   Ischemic Cardiomyopathy;   Heart Failure, Systolic;   Heart Failure NYHA Class III;   Heart Failure NYHA Class II;   Heart Failure NYHA Class IV;   Coronary Artery Disease
Interventions:   Procedure: Epicardial AAMs-patch transplantation;   Diagnostic Test: RNA-stabilized whole blood sampling;   Diagnostic Test: Plasma sampling;   Diagnostic Test: Transthoracic echocardiography;   Diagnostic Test: Late-gadolinium enhancement cardiac magnetic resonance imaging (LGE-CMRI);   Other: Symptom-scaling;   Other: 6-minute walking test (6MWT);   Diagnostic Test: Blood sampling (NT-proBNP);   Diagnostic Test: Transesophageal echocardiography
Sponsors:   Hospital District of Helsinki and Uusimaa;   University of Helsinki
Not yet recruiting
Posted: Tuesday, November 22, 2022 - 12:00
Conditions:   Myocardial Reperfusion Injury;   Treatment Outcome;   Prognosis;   ST Elevation Myocardial Infarction
Intervention:   Device: Extracorporeal cardiac shock wave therapy(ECSW)
Sponsor:   The First Affiliated Hospital of Kunming Medical College
Not yet recruiting
Posted: Thursday, October 27, 2022 - 12:00
Conditions:   Diabetic Foot Ulcer;   Mesenchymal Stromal Cells
Intervention:   Drug: Adipose tissue derived mesenchymal stromal/stem cells (Cell2Cure®)
Sponsor:   Cell2Cure ApS
Not yet recruiting
Posted: Thursday, September 29, 2022 - 12:00
Condition:   Ischemic Bowel Disease
Intervention:   Other: Human Umbilical Cord blood mononuclear cells
Sponsor:   Qianfoshan Hospital
Posted: Thursday, September 22, 2022 - 12:00
Condition:   Venous Leg Ulcer
Interventions:   Biological: XSTEM-VLU;   Other: Vehicle
Sponsors:   Xintela AB;   Vinnova
Not yet recruiting
Posted: Wednesday, August 24, 2022 - 12:00
Conditions:   Hypoxic-Ischemic Encephalopathy;   Neonatal Asphyxia;   Neonatal Encephalopathy
Interventions:   Drug: Normal Saline along with standard treatment;   Drug: Sovateltide along with standard treatment
Sponsor:   Pharmazz, Inc.
Not yet recruiting
Posted: Friday, June 10, 2022 - 12:00
Conditions:   Heart Disease, Ischemic;   Hyperlipidemias;   Hypertension
Intervention:   Other: Whole-Food, Plant-Based Diet and Low-Carbohydrate Diet
Sponsor:   University of Rochester
Not yet recruiting